Pharmapriser ApS: Financial statements 2022
CVR: 36479868
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Pharmapriser ApS (CVR 36479868) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 87,166 and a net result of DKK 16,678 compared with DKK 18,881 the year before. That is an increase of 11.6% compared with the year before. The profit margin was 19.1%. Equity in the 2022 report amounted to DKK 105,213. The solvency ratio was 100%.
- Revenue
- DKK 87,166
- Gross Profit
- DKK 16,678
- Profit/Loss
- DKK 16,678
- Equity
- DKK 105,213
- Total Assets
- DKK 105,213
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 87 t. | 17 t. | 17 t. | 105 t. | - |
| 2021 | 78 t. | 24 t. | 19 t. | -41 t. | - |
| 2020 | 44 t. | -4 t. | -3 t. | -59 t. | - |
| 2019 | 14 t. | 1 t. | 1 t. | -57 t. | - |
| 2018 | 19 t. | -77 t. | -77 t. | -72 t. | - |
Official annual report
Keep an eye on Pharmapriser ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Pharmapriser ApS has published its annual report for 2021. Revenue came to DKK 78,093, and the net result was DKK 18,881.
About Pharmapriser ApS
Pharmapriser ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2014. The company is registered under the industry Detailhandel med tøj. The company was previously named MAIN COPENHAGEN ApS. The management consists of Christian Frisch and Oscar Thalund-Jørgensen. The company is owned by JF Consolidated ApS. In 2025, the company reported a gross profit of DKK -6,263 and a net result of DKK -8,073 compared with DKK -1,860 the year before. Equity in the 2025 report amounted to DKK 40,067.